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Abstract
 
Interleukin 7 is a crucial factor for the development of murine T and B lymphocytes. We now
report that, in the absence of interleukin 7, B lymphocyte production takes place exclusively
during fetal and perinatal life, ceasing after 7 wk of age. In peripheral organs, however, the pool
of B lymphocytes is stable throughout adult life and consists only of cells that belong to the B1
and marginal zone (MZ) compartments. This is accompanied by a 50-fold increase in the fre-
quency of immunoglobulin (Ig)M- and IgG-secreting cells, and the concentration of serum
immunoglobulins is increased three- to fivefold. Both the MZ phenotype and the increase in
serum IgM are T cell independent. These findings reveal a previously undescribed pathway of
B lymphopoiesis that is active in early life and is interleukin 7 independent. This pathway gen-
erates B1 cells and a normal sized MZ B lymphocyte compartment.
Key words: B lymphocyte • interleukin 7 • marginal zone B cells • B1 cells • B cell 
development
 
Introduction
 
Murine B lymphocyte development initially takes place in
the fetal liver, shifting after birth to the bone marrow,
where it occurs throughout adult life. Precursor popula-
tions are phenotypically well characterized and expression
of various surface markers allowed the subdivision of pre-
cursor B cells into sequentially developing populations (1).
During B lymphocyte development in the bone marrow,
IL-7, produced by stromal cells, plays a crucial role in the
expansion and survival of those precursors (2). The identifi-
cation of the receptor complex for IL-7 revealed that it is
composed of a private 
 

 
 chain, IL-7R
 

 
 (3), and the com-
mon 
 

 
 chain (
 

 
c), shared with other cytokine receptor
complexes (4). Severe lymphopenia occurs in mice made
deficient for either IL-7 (5) or IL-7R
 

 
 (6), demonstrating
the fundamental role played by this receptor/ligand system
in lymphopoiesis. Both mutant strains of mice display a 10-
fold reduction in the number of peripheral T and B cells,
but their phenotype does not seem to be identical. Thus,
IL-7R
 

 
–/–
 
 mice show an arrest in B cell development at
the transition from Hardy’s fraction (1) A to fraction B (6),
while the blockage in B cell development in IL-7
 

 
/
 

 
 mice
was described as occurring from fractions B/C to D (5).
The final outcome of this process of lymphopoiesis is a
peripheral B lymphocyte compartment consisting of a ma-
jority of small resting cells, but containing also around 10%
of activated cells (7). A defined population of activated B
cells are the marginal zone (MZ)
 
*
 
 cells which exhibit a
phenotype characterized by the expression of high levels of
IgM and CD21 on their surface, together with low levels
of IgD and CD23. This is in contrast to the majority 90–
95% of follicular (FO) B lymphocytes which display an op-
posite phenotype (IgD
 
hi
 
CD23
 
hi
 
CD21
 
lo
 
), consistent with a
resting state. Multireactive cells, with “sticky” antigen re-
ceptors, appear to be recruited efficiently into the MZ and
respond promptly to stimulation by LPS or CD40 ligation
whereas FO B lymphocytes respond to B cell receptor
(BCR)-dependent stimulation, and are thought to be re-
sponsible for the production of high affinity antibodies and
memory cells (8, 9). A distinct subpopulation of B lympho-
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cytes displaying activation markers, B1 cells, is enriched in
the peritoneal cavity and appears to derive from precursors
generated early in development (10, 11). These B1 cells
were shown to express Ig receptors with fewer N sequence
additions than the conventional B2 cells (12, 13) and pref-
erentially secrete auto- and multireactive antibodies (14).
In the present work we examine the development, per-
sistence, and activation of B lymphocytes in mice deficient
for IL-7. We show that the bulk of B lymphocytes in IL-
7
 

 
/
 

 
 mice has a fetal and perinatal origin, because, contrary
to previously held beliefs, B cell development in adult bone
marrow is arrested at a very early stage, before the transi-
tion to fraction B. In agreement with this finding, the ma-
jority of B lymphocytes found in the spleen of adult IL-7
 

 
/
 

 
mice carry little or no N sequence additions at their VDJ
borders. Nevertheless, the pool of peripheral, mature B
lymphocytes in these mice is stable in numbers, at some
10% of control levels, and consists predominantly of large
activated cells with a phenotype closely resembling that of
MZ cells. This phenotype is observed even when thymus-
derived lymphocytes are absent, as shown by the analysis of
athymic nu/nu, IL-7
 

 
/
 

 
 mice. Furthermore, the lym-
phopenia caused by the lack of IL-7 affects neither the B1
population nor the levels of serum Ig, as IL-7
 

 
/
 

 
 mice have
in fact more circulating antibodies than wild-type controls.
 
Materials and Methods
 
Mice.
 
The IL-7–deficient mice were derived from chimeras
obtained by microinjecting the original IL-7 targeted ES cell line
(5) in C57BL/6 blastocysts. The mice used in this study were
backcrossed with C57Bl/6 for at least six generations. Nu/nu, IL-
7
 

 
/
 

 
 mice were obtained by crossing fully inbred (N10) IL-7
 

 
/
 

 
mice to C57BL/6J nu/nu animals obtained from The Jackson
Laboratory. C57BL/6 mice were used as wild-type controls and
were originally purchased from The Jackson Laboratory. All mice
were bred and kept in our animal facilities in Oeiras under spe-
cific pathogen-free (SPF) conditions.
 
Cell Purification and Counting.
 
Single cell splenocyte suspen-
sions were obtained by disrupting spleens with a nylon mesh in
FACS
 
®
 
 medium (PBS, 2% FCS, 0.02% NaN
 
3
 
). Bone marrow
cells were obtained by flushing femurs with 2 ml of FACS
 
®
 
 me-
dium using a 27 1/2 gauge needle. Peritoneal cavity exudate cells
were collected by injecting peritoneal cavities with 10 ml of
FACS
 
®
 
 medium using a 27 1/2 gauge needle. After a gentle mas-
sage the liquid was recovered with a 20 gauge needle. Cells were
counted in a Burker chamber under a light microscope excluding
dead cells with Trypan blue (Sigma-Aldrich).
 
Antibodies, Staining, and FACS
 
®
 
 Analysis.
 
FITC-, PE-, allo-
phycocyanin (APC)-, or biotin-conjugated antibodies against
B220 (RA3–6B2), CD11b/Mac-1 (M1/70), CD19 (1D3),
CD21 (7G6), CD23 (B3B4) heat stable antigen (HSA) (M1/69),
CD43 (S7), BP-1 (6C3), and IgD (11–26c.2a) were purchased
from BD PharMingen. Polyclonal, 
 

 
 chain specific, FITC-
labeled anti-IgM was obtained from Pierce Chemical Co. and
PE-conjugated monoclonal anti-IgM antibody 1B4B1 was ob-
tained from Southern Biotechnology Associates, Inc. 10
 
6 
 
cells per
well were incubated with 25 
 

 
l of pretitrated antibody in 96-
well plates (Costar) on ice for 20 min in the dark. The cells were
then washed three times with FACS
 
®
 
 medium before analysis.
Biotinylated antibodies were revealed with APC-, PE-, or
FITC-conjugated streptavidin (BD PharMingen), after washing
twice. Samples were analyzed on FACScan™ or FACSCalibur™
flow cytometers (Becton Dickinson), and dead cells were ex-
cluded with propidium iodide.
 
Analysis of B Cell Precursor Frequencies.
 
Bone marrow precur-
sor cells (B220
 

 
IgM
 

 
 or CD19
 

 
IgM
 

 
) were purified by cell
sorting, using a FACStar
 
PLUS™
 
 (Becton Dickinson), to a purity
 

 
98%. The cells were then plated under limiting dilution condi-
tions in 96-well plates (48 wells/dilution) at 100, 33, and 11
cells/well (in the case of B220
 

 
IgM
 

 
) or 10, 3.3, and 1.1 cells/
well (in the case of (CD19
 

 
IgM
 

 
) onto irradiated (2,000 Gy)
S17 stromal cells in culture medium (Opti-MEM [GIBCO
BRL]), with 10% FCS, Pen/Strep, and 
 

 
M-E), supplemented
with excess IL-7 and Stem cell factor (c-kit ligand), as described
previously (15). Growth of lymphocyte colonies was scored at
day 7 of culture.
 
CDR3 Cloning and Sequencing.
 
Cell separation was per-
formed by midiMACS magnetic sorting, according to the manu-
facturer’s protocol (Miltenyi Biotec). CD19
 

 
 cells from the
spleen of IL-7
 

 
/
 

 
 and C57/Bl6 mice were purified using FITC-
conjugated anti-CD19 antibody and anti-FITC MicroBeads
(Miltenyi Biotec). Purity was 
 

 
95%, as verified by FACS
 
®
 
 analy-
sis. DNA from 5 
 
	
 
 10
 
6
 
 CD19
 

 
 cells was obtained by incubating
at 37
 


 
C overnight in DNA quick lysis solution (50 mM Tris-
HCl, pH 7.6, 1 mM EDTA, 100 mM NaCl, 0.2% SDS) contain-
ing 100 
 

 
g/ml proteinase K, precipitated with 3 volumes of ice
cold absolute ethanol and 0.1 volumes of 5 M NaCl, washed in
70% ethanol, and resuspended in milliQ water. J558 rearrange-
ments were amplified with the following primers: VHJ558 AAG-
GCCACACTGACTGTAGAC (sense), and C
 

 
 CTGGATC-
CGGCACATGCAGATCTC. PCR was performed with 1.5
 

 
M MgCl
 
2
 
, 0.2 
 

 
M dNTP’s, 0.2 
 

 
M of each primer, and 0.25
 

 
l of 5 U/
 

 
l Taq polymerase using manufacturer’s buffer (Life
Technologies). Reactions were incubated at 94
 


 
C for 2 min, and
then run through 35 cycles of 94
 


 
C for 1 min, 60
 


 
C for 1 min,
and 72
 


 
C for 1 min, with a final extension of 10 min at 72
 


 
C. A
750-bp band, corresponding to J558-JH4 rearrangements from
this reaction was purified from a 0.8% agarose gel by gel extrac-
tion (QIAGEN). Purified fragments were then cloned using the
TA cloning kit from Invitrogen according to the manufacturer’s
instructions. Ampicilin resistant clones were screened by PCR
for recombinants, and positive clones were sequenced using Big-
Dye Terminator Cycle-sequencing kit (Applied Byosystems),
with 3.2 pM of either Sp6 primer, ATTTAGGTGACACTATA,
or M13(-20) forward primer, GTAAAACGACGGCCAG, de-
pending on insert orientation. Sequencing was performed on an
ABI Prism 377 (PerkinElmer) automatic sequencer, and the re-
sults were analyzed with Sequencher software (Gene Codes).
 
ELISA and ELISA Spot Assay.
 
Sera were obtained from tail
bleeding and kept at –20
 


 
C until used. Total IgM, IgG, and IgA
concentrations were determined by ELISA as described else-
where (16) using monoclonal antibodies of each class as standards.
Results are presented as 
 

 
g/ml equivalents of the standard pro-
tein. Total IgM and IgG plasma cell numbers in ex vivo experi-
ments were determined by a modification of the method de-
scribed elsewhere (16). Briefly, flat-bottom 96-well plates
(Luxlon M29 LSE; CEB) were coated with anti-IgM or anti-IgG
antibodies (Southern Biotechnology Associates, Inc.). The plates
were blocked with 1% gelatin for 1 h, and the cells were seeded
according to a serial dilution and incubated at 37
 


 
C overnight.
After washing, the spots generated by the binding of secreted Ig
were revealed with alkaline phosphatase–conjugated anti–mouse
 1143
 
Carvalho et al.
IgM or IgG (Southern Biotechnology Associates, Inc.) for 90 min
at 37
 


 
C. The development of an alkaline phosphatase reaction
was obtained by the use of the substrate 5-bromo-4-chloro-3-
indolyl phosphate (Sigma-Aldrich). The fraction of plasma cells
per cells seeded was determined by counting the number of spots
in at least three different dilutions. When evaluating the number
of plasma cells in various organs, the number of spots was further
adjusted according to the number of B cells as determined by
FACS
 
®
 
 analysis.
 
Results
 
B Lymphocytes Do Not Accumulate with Age in IL-7
 

 
/
 

 
Mice.
 
Deficiency in IL-7 leads to a severe reduction in the
number of both T and B lymphocytes in peripheral organs
(5). To examine whether the lymphopenia in the B cell
compartment persists throughout the life of IL-7
 

 
/
 

 
 mice
we determined the number of B220
 

 
IgM
 

 
 cells present in
the spleen, from birth until 7 mo of age. Fig. 1 shows that
the number of splenic B lymphocytes found in IL-7
 

 
/
 

 
 and
control mice increases exponentially only until the age of 6
wk, and from then on remains constant. At all ages tested
the number of B lymphocytes in the spleen of IL-7
 

 
/
 

 
mice is reduced by 
 

 
10-fold when compared with age-
matched wild-type controls.
 
Bone Marrow Lymphopoiesis Is Blocked at an Early Stage in
IL-7
 

 
/
 

 
 Mice.
 
The observation that IL-7
 

 
/
 

 
 mice cease
to accumulate B lymphocytes at around 6 wk of age,
maintaining a severe lymphopenia throughout life, led us
to investigate if production of B cells occurs in adult mice,
albeit at reduced levels. Development of B lymphocytes
from hematopoietic precursors has been subdivided into
fractions A (the more immature) to F (the more mature,
IgM
 

 
IgD
 

 
 population) according to the expression of var-
ious surface markers (1). IL-7 deficiency is thought to
cause a blockade at the transition of precursor B cells from
fractions B/C to D (5).
We analyzed the populations of precursor B lympho-
cytes in IL-7
 

 
/
 

 
 mice by flow cytometry using the marker
CD19, which is expressed by B lineage cells after fraction A
(17). This surface marker is known to be more specific for
precursor B lymphocyte populations than B220 (CD45R),
which is also expressed by other cells in the bone marrow,
for example NK cells (18).
Fig. 2 a shows that the population of B220
 

 
IgM
 

 
CD19
 

 
 cells, which contains pro- and pre-B cells,
easily detectable in the bone marrow of wild-type animals,
is much reduced in IL-7
 

 
/
 

 
 mice already at 1 wk of age
and by the time the animals reach 7 wk this population is
almost completely absent. Because cells in fraction B al-
ready express CD19, this result shows that, in contrast to
previous convictions, the block in B lymphocyte develop-
ment observed in adult IL-7
 

 
/
 

 
 mice occurs before the
transition to this population. Moreover, as shown in Fig. 2
b, the B220
 

 
IgM
 

 
 population in the bone marrow of
adult IL-7
 

 
/
 

 
 mice express neither BP-1 (19) nor HSA
(HSA/CD24), two other markers found in precursor B
lymphocytes (1).
Finally, as shown in Table I, the frequency of B cell pre-
cursors in either CD19
 

 
IgM
 

 
 or B220
 

 
IgM
 

 
 cells purified
from the bone marrow of young mice is comparable in
control and in IL-7
 
–/–
 
 mice (1/6 vs. 1/4 and 1/50 vs. 1/80,
respectively). In contrast, in the case of adult mice (where
there are no CD19IgM in IL-7–/– mice) this frequency
among the B220IgM population is 1/240 in control
mice, but below 1/6,500 for IL-7–/– animals. These results
show that B lymphopoiesis in the bone marrow of IL-7–/–
mice is already reduced some 40-fold in the total number
of B cell precursors at 1 wk of age. At 7 wk of age both the
absence of CD19 cells in the bone marrow and the unde-
tectable frequency of B cell precursors in vitro indicate a
virtual absence of B lymphopoiesis.
B Lymphocytes in IL-7/ Mice Do Not Express an Adult
Repertoire. Variable region genes in B lymphocytes of
young mice characteristically lack N sequence additions
(12, 20, 21) due to the developmental regulation of the
enzyme TdT (22). Because of the block in adult B lym-
phopoiesis shown above, we determined N nucleotide ad-
ditions by sequencing junctional segments where VHJ558
rearranged to JH4 in 6-wk-old mice. The full sequence of
the J558 locus is not known, so we considered the end of
the germline VH J558 segments to be the predominant
Cys-Ala-Arg motif. D elements were identified as the
longest stretch of nucleotides between the VH and the
JH4 genes that showed sequence identity to published D
segments.
Figure 1. Adult IL-7/ mice do not accumulate B cells in the periph-
ery. Spleen cell suspension from C57BL/6 and IL-7/ mice were pre-
pared at the indicated ages and the number of live B220IgM B cells
was determined. The figure shows the logarithmic mean and standard de-
viations of three to five animals per time point.
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Table II shows 19 such sequences from IL-7/ and 5
from wild-type mice. All of the wild type sequences
showed N additions at both the V-D and the D-J borders,
as described previously (12, 13). In contrast, of the 19 se-
quences from IL-7/ mice analyzed, only 6 showed a sim-
ilar pattern with more than one N nucleotide at both the
V-D and the D–J junctions. In accordance with these re-
sults, CDR3 length analysis of VHQ52 family rearrange-
ments revealed a shorter average length in IL-7/ mice
compared with control mice (not shown). We also se-
quenced VDJ rearrangements in the fetal liver of IL-7/
and wild-type mice and found no N sequence additions in
both cases (not shown).
B1 Cells Are Normally Represented in IL-7/ Mice. A
population of B lymphocytes which express an activated
phenotype, named B1 cells, is long-lived, self renewing,
and persists independently of adult bone marrow lym-
phopoiesis (11, 23). These cells have little or no N sequence
additions at their VDJ borders (13, 24) and are enriched in
the peritoneal and pleuropericardial cavities, where they
express Mac 1 (CD11b) (25) and CD5 (in the case of B1a
cells) (26). Splenic B1 cells, on the other hand, are negative
for Mac 1, but were described as CD23lowCD43 (27).
We examined peritoneal B cells by flow cytometric anal-
ysis for the expression of Mac 1. Fig. 3 a shows that essen-
tially all the B cells recovered from the peritoneal cavity of
IL-7/ mice are Mac 1 B1 cells, whereas wild-type mice
show a prominent Mac 1 B2 population that represents
40% of the B lymphocytes in the peritoneal cavity. The
overall distribution of peritoneal B1a and B1b cells is not
significantly altered in IL-7/ mice, as seen by the propor-
Figure 2. Bone marrow B lymphopoiesis is arrested in adult IL-7/ mice. (a)
Expression of B220, IgM, and CD19 by wild-type (left) and IL-7/ (right) bone
marrow cells. Dot plots show B220/IgM stainings and the B220IgM gate used
for histogram analysis. Histograms show the percentage of CD19 cells in the
B220IgM population. Numbers represent percentage of live lymphoid cells in
the bone marrow. The average number of cells recovered from the femurs of wild-
type and IL-7/ were the following: wild-type 6.106 ( 2.3), 25 	 106 ( 7.0),
and 30.8 	 106 ( 4.5); IL-7/ 4.8 	 106 ( 0.5), 12.6 	 106 ( 4.5), and
19.4 	 106 ( 6.3), at 1, 4, and 7 wk of age, respectively. Results are representa-
tive of at least three mice for each age. (b) Expression of CD24 (HSA) and BP-1
among B220IgM (left histogram) and B220 (right histogram) cells in the bone
marrow of wild-type (open) and IL-7/ (filled) mice.
Table I. Frequency of B Cell Precursors Among Bone
Marrow Cells
Age Population C57BL/6 IL-7/
1 wk old CD19IgM 1/6 1/4
B220IgM 1/50 1/80
8–10 wk old B220IgM 1/240 1/6,500
Frequency of cells capable of giving rise to B cell colonies in stromal
cultures supplemented with IL-7 and stem cell factor. The populations
were purified to 98% by cell sorting, from the bone marrow of
C57BL/6 or IL-7/ mice, as indicated. For details of the in vitro assay
see Materials and Methods.
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tions of CD5 and CD5 cells among the Mac 1 B cells
(Fig. 3 b). The lack of B2 cells in the peritoneal cavity of
IL-7/ mice is reflected in the absence of IgMlo–intIgDhi B
cells (not shown).
In the spleen of adult IL-7/ mice around 15–20% of
the B lymphocytes express CD43 and low levels of CD23
(i.e. they are B1 cells). This compares to the 1–2% B1 cells
detected in control mice (Fig. 3 c). Because in IL-7/
mice the reduction in the total number of splenic B cells is
12-fold (see Fig. 1), this result shows that also in the spleen
the actual number of B1 cells is similar in IL-7/ and in
wild-type mice.
A High Proportion of Mature Splenic B Cells in IL-7/
Mice Display an Activated Phenotype. B cell lymphopenia is
frequently associated with altered proportions of peripheral
resting and activated cells (28, 29). Most of the large acti-
vated cells in the spleen are found associated to the macro-
phage population in the MZ, while most of the small rest-
ing B cells localize to the T cell rich areas of the follicles
(8). These two populations differentially express various
surface markers (30).
Fig. 4 shows that most B cells (B220IgM) from IL-7/
mice have a higher forward scatter (FSC), express high
levels of IgM and CD21 and lower levels of IgD and
CD23, when compared with splenocytes from wild-type
mice. Splenic B cells from IL-7/ mice, in addition, re-
spond to LPS at doses as low as 0.25 g/ml (not shown),
which is a characteristic of MZ cells (8). As shown above,
only 20% of these cells are CD43, therefore we conclude
that most B lymphocytes present in the spleen of adult IL-
7/ mice are activated cells with a phenotype very similar
to that of MZ B cells in normal mice.
In IL-7/ mice, the reduced number of T lymphocytes
present in the spleen also display markers compatible with
high levels of activation (unpublished data). We therefore
assessed whether the increased B cell activation is a prop-
Table II. N-Additions at Ig CDR3
VH V/N/P D N/P JH4
C57BL/6
TAC TGT GCA AGA CAG A TC TAC TAT GGT AAC TAC GTG TAC TAT GCT ATG GAC TAC TGG GGN
TAT TGT GCA AGA GCG GAG GC C TAT GAT TAC GAC TAT TAC TAT GCT ATG GAC TAC TGG GGT
TAC TGT GCA AGA GAG G AT TAC T CC T CT ATG GAC TAC TGG GGT
TAC T CT TCC ATT ACG AC G AGA GGA CTA CTG GGGa
TAT TGT GCA AGA GAT AGC TCA GGC TAC GTA GAG GCT ATG GAC TAC TGG GGT
IL-7/
TAT TGT GCA AG T GG C TAT GCT ATG GAC TAC TGG GGT
TAT TGT GCA AG T AGC TAC TAC TAT GCT ATG GAC TAC TGG GGT
TAT TGT GCA AGA CTA CGG TAC TAT GCT ATG GAC TAC TGG GGT
TAC TGT GCA AGA TAT GGT TAC G AC TAT GCT ATG GAC TAC TGG GGT
TAT TGT GCA N AT GGT TAC T AC TAC TGG GGT
TTC TGT GCA AGA G AC GGT A AT GCT ATG GAC TAC TGG GGT
TAC TGT GCA A CC C AG TAT GCT ATG GAC TAC TGG GGT
TAC TGT GCA AGG G GG TA A CTA TGC TAT GGA CTA CTG GGGa
TTC TGT GCA A A T CTA CTA TGA TTA CGA T TA CTA TGC TAT GGA CTA CTG GGGa
TTC TGT GCA AGG GGG TAT TAC TAC GGT AGT AGC T T C TAT GCT ATG GAC TAC TGG GGT
TTC TGT GCA AGA AGG TAC TAC GGT AGT AGC T C C TAT GCT ATG GAC TAC TGG GGT
TAC TGT GCA AGA T CG G AG TAT GCT ATG GAC TAC TGG GGT
TAC TGT GCA AGA T CT ATG ATT ACG AC G A AC TAT GCT ATG GAC TAC TGG GGT
TAC TGT GCA A TA TTA TTA CGG TCC G AT GCT ATG GAC TAC TGG GGT
TAC TGT GCA AGA TGG GGT ACT AC A GGG GG T ATG GAC TAC TGG GGT
TTC TGT GCA AGA TCG A GA TT C CTG CT T ATG GAC TAC TGG GGT
TAC TGT GCA AGA GGG AGG AAT TCT A TC TAT GAT GG C CAC CCT CT C TAT GCT ATG GAC TAC TGG GGT
TAC TGT GCA AGA TAC GGT A AA AAG ACT AT C TAT GCT ATG GAC TAC TGG GGT
TAC TGT GCA AGA GGG AC A GCT CAG GGC CTT C TAT GCT ATG GAC TAC TGG GGT
Sequences of VHJ558-JH4 rearrangements obtained from 6-wk-old wild-type (top) and IL-7/ (bottom) mice. The end of germline VHJ558 was
defined as the dominant Cys-Ala-Arg motif (TGT GCA AGA or TGT GCA AGG). Sequences were considered in–frame when the Cysteine from
the VHJ558 segment and the Tryptophane from the JH4 segment were in the same uninterrupted reading frame. 
aOut–of–frame sequence.
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erty of the B lymphocyte compartment or rather a conse-
quence of T cell hyperactivity. Fully inbred (N10) IL-7/
mice were crossed to C57BL/6J nu/nu animals in order to
obtain athymic animals deficient for IL-7. In the spleen of
such IL-7/, nu/nu mice CD3 T lymphocytes are virtu-
ally undetectable, in contrast to the small (1–3%) popula-
tion of CD3 cells present in IL-7/, nu/nu animals (not
shown). As shown in Fig. 5, the majority of the B lympho-
cytes present in the spleen of IL-7/, nu/nu mice consist
of large, CD21hiCD23lo cells that resemble MZ B lympho-
cytes, similarly to what is observed in IL-7/ mice.
Plasma Cell Numbers and Serum Antibody Levels in IL-7/
Mice Are Higher than Normal. Normal, unimmunized
mice maintain a constant level of serum Ig resulting from
endogenous activation of B lymphocytes and their differen-
tiation into plasma cells. These natural antibodies are found
even in mice kept under germ-free conditions and fed
chemically defined diets (7).
We determined the number of plasma cells in the
spleen and bone marrow of IL-7/ and wild-type mice
and measured their levels of serum IgM, IgG, and IgA.
ELISA-spot analysis shows a 30- to 50-fold increase in
the frequency of IgM- and IgG-secreting plasma cells in
the spleen of IL-7/ compared with control mice. The
frequency of bone marrow IgM secreting plasma cells is
also increased 50-fold in IL-7–deficient mice (Fig. 6 a).
Fig. 6 b shows that IL-7/ mice have elevated titers of
serum antibodies relative to control mice. The concen-
trations of Ig were fivefold higher for IgM, and threefold
higher for IgG and IgA in the serum of IL-7/ than in
wild-type mice. Serum antibody levels remained higher
in IL-7/ mice at least until 4 mo of age. Serum IgM ti-
ters were also approximately twofold elevated in IL-7/,
nu/nu mice, compared with control nu/nu animals (not
shown).
Figure 3. B1 lymphocytes are present in normal numbers. (a) Percent-
age of Mac-1 and Mac-1 B cells (IgM) in the peritoneal cavity at 8 wk
of age. Plots were gated to exclude dead cells, peritoneal macrophages,
and granulocytes. (b) CD5 expression on gated peritoneal B1 cells (filled
line) and on IgM cells (open line) from C57BL/6 (left panel) or IL-7/
(right panel) mice. (c) CD23 and CD43 expression by gated IgM cells in
the spleen of C57BL/6 (left panel) or IL-7/ (right panel) mice. The
numbers in the panels represent the percentage of CD23lowCD43 cells.
Figure 4. IL-7/ mice B lymphocytes are predominantly activated
cells. Expression of activation markers by splenic B cells of IL-7/ and
wild-type mice at 10 wk of age. Dot plots on the left show the
B220IgM gate used for histogram analysis in wild-type (top) and IL-7/
(bottom) cells. Histograms on the right show from top to bottom the size of
B220IgM cells of wild-type (open) and IL-7/ (filled) mice, measured
by FSC, and the expression of CD21, CD23, and IgD. Splenocytes were
gated for live lymphoid cells, and the results are representative of more
than 20 adult animals analyzed.
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Discussion
This work shows that in mice deficient for IL-7 the bone
marrow ceases to produce significant numbers of B lym-
phocytes after 7 wk of age. In IL-7/ mice the percentage
of precursor B lymphocytes (B220IgMCD19) de-
creases from 0.2% of total bone marrow cells at 1 and 4 wk
of age to below 0.01% at 7 wk. In wild-type mice, in con-
trast, the frequency of precursors increases from 10 to 20%.
Because the cellularity of the bone marrow is similar in
both strains of mice (5; and our observations) this leads to a
1,000	 reduction in the number of pro- and pre-B cells
in adult IL-7–/– mice. Curiously, B lymphocytes accumu-
late in the periphery at the same rate and over the same
time period as in control mice, suggesting either a more ef-
ficient recruitment of B cells into the peripheral pool, or a
higher rate of peripheral expansion. In spite of the absence
of newly generated B cells, the peripheral compartment
maintains constant numbers throughout adult life, at a level
10% of normal. Most splenic B lymphocytes in adult IL-
7/ animals carry little or no N-sequence additions at
their VDJ borders, which is consistent with their produc-
tion during fetal and perinatal life, before expression of
TdT. In spite of the severe lymphopenia, the mice have
higher than normal titers of Ig in their serum and an in-
creased frequency of plasma cells secreting IgM and IgG.
The defect described here resembles that reported for
mice deficient in the expression of 5, where a severe lym-
phopenia and stunted B cell development are also associ-
ated with elevated serum IgM (29). A crucial difference
however is that 5-deficient mice accumulate cells with
time and approach normal B cell numbers after 4–6 mo of
age. This is not the case in IL-7/ mice, where B cell
numbers always parallel those of wild-type animals, with a
reduction of little over one order of magnitude.
The conclusion that the block in B cell development
seen in IL-7/ mice after 7 wk of age occurs at the tran-
sition between Hardy’s fractions (1) A to B, and not B/C
to D as originally described (5), is supported by several
pieces of evidence. The population of B220IgM cells
in the bone marrow of adult IL-7/ mice does not ex-
press the coreceptor molecule CD19, a marker specific
for the B cell lineage (17, 18). The same population does
not express other markers found on precursor B cells, like
BP-1 (19) and, contrary to the original publication de-
scribing the IL-7/ mice (5), we could not detect
expression of HSA/CD24. Although some of the
B220IgM cells, which are CD19 in IL-7/ mice,
may represent very early B cell precursors as described
(17, 31), we show that the frequency of cells in this popu-
lation capable of giving rise to B cells in culture is below
1/6,500 in IL-7/ mice, whereas it is 1/240 for
B220IgM isolated from C57BL/6 mice. It is known
that B lymphocytes generated during perinatal life have
little diversification at the VDJ junctions (12, 20, 21),
therefore the finding that most B cells present in the
spleen of adult IL-7/ mice have little N-sequence addi-
tions suggests that they were produced during the fetal
and neonatal period. Both IL-3 (32) and thymic stromal
lymphopoietin (TSLP) (33) are candidate factors for sup-
porting B lymphopoiesis in young mice, but it is evident
from the data that they play a minor role, if any, during
adult bone marrow lymphopoiesis.
A significant proportion of the B220IgMCD19 pop-
ulation expresses the NK 1.1 marker both in IL-7/ mice
(not shown) and in wild-type mice, as reported (18; and
not shown). Our results therefore offer another interpreta-
tion to the observation that the population in IL-7/ mice
does not express TdT and C (34). Other studies that
identify these B220IgM cells as B lymphocyte precursors
(35) need to be reevaluated in light of the present results.
Splenic B cells in adult IL-7/ mice display an activated
phenotype, in some ways resembling that of B1 cells (11).
These cells express CD43 (27) and are enriched in the peri-
toneal cavity, where they also express the Mac 1 marker
(25). Most B lymphocytes in the spleen of IL-7/ mice
have very few or no N-sequence additions, similarly to B1
cells (13), and 20% of them are CD43, indicating that the
splenic B1 compartment is of normal size. We find that the
severe lymphopenia observed in IL-7/ mice does not af-
fect the number of peritoneal Mac 1 B cells and also that
Figure 5. B lymphocytes in IL-7/
mice are predominantly activated in the
absence of thymus-derived cells. Expres-
sion of B cell activation markers in
splenic B lymphocytes from IL-7/, nu/
nu and C57BL/6J nu/nu mice at 7 wk of
age. The histograms show, from top to
bottom, the size of B220IgM cells of
C57BL/6J nu/nu (open), and IL-7/,
nu/nu (filled) mice, measured by FSC,
and the expression of CD21, CD23, and
IgD. Splenocytes were gated for live B
cells as in Fig 4. The result is representa-
tive of two adult animals analyzed.
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the proportions of peritoneal B1a (CD5) and B1b (CD5)
lymphocytes are normal.
In a normal animal the bulk of B cells are resting, have a
small size, and express high levels of IgD, whereas most B
lymphocytes in IL-7/ mice are IgDlow. A predominance
of IgDlow cells was reported for IL-7R–deficient mice,
which was interpreted as representing immature B cells
(36). This is not the case in IL-7/ mice, because most
cells are mature activated B lymphocytes (CD21hi
CD23loIgDlo and large size as measured by their FSC pro-
file). Approximately 80% of these cells are CD43, there-
fore they do not belong to the B1 lineage and their pheno-
type is very similar to what was reported for MZ B cells (8)
although direct histological evidence for the existence of a
MZ in IL-7/ mice is lacking. The B cells in the spleen of
IL-7/ mice also promptly respond to doses of LPS as low
as 0.25 g/ml (not shown), another characteristic of MZ
cells (8).
The B cell activation and higher than normal levels of
serum Ig and plasma cells in IL-7/ mice may be the result
of disregulation in whatever mechanisms are responsible for
controlling the compartment of activated and Ig-secreting
peripheral B cells. Evidence for T cell control of the size of
the B cell compartment comes from studies conducted in
mice made deficient for the common cytokine receptor 
chain (37). It would be possible, therefore, that the alter-
ation observed in the B cell compartment of IL-7/ mice
is secondary to the T cell lymphopenia. However, it is un-
likely to be simply the result of it since T cell–deficient
mice (nude or T cell receptor knockout mice) do not show
this prominent phenotype of B cell activation and high lev-
els of serum Ig. The analysis of IL-7/ nude mice allowed
us to determine that the prominent B lymphocyte activa-
tion is T cell independent because, in the absence of thy-
mus derived T cells, the majority of the B cells are still
CD21hi and CD23lo. The only difference we observed
when comparing IL-7/, /, and IL-7/, nu/nu mice
is the appearance of a somewhat larger population, yet not
exceeding 40% of the splenic B cells, of small IgDhi lym-
phocytes (compare Figs. 4 and 5). It may be that a fraction
of the B cells in IL-7/ mice are activated by T cell–depen-
dent mechanisms, but the B lymphocytes that do develop
in the absence of IL-7 still replenish a normal sized MZ
compartment and the FO B cell pool is severely depleted,
even when thymus-derived cells are absent. Consistent
with these results is the observation that also in IL-7/,
nu/nu mice the level of serum IgM is elevated relative to
the level found in C57BL/6J nu/nu (not shown).
The high activation level of the B cells could also be the
result of external pathogen pressure on a quantitatively lim-
ited immune system. This hypothesis is unlikely because
our mice were raised under SPF condition, and because the
high frequency of plasma cells in IL-7/ is already evident
in 10-d-old animals (not shown).
Soluble factors encountered during development can
modulate activation thresholds and influence cell fate deci-
sions, namely activation and Ig secretion, as shown for type
I interferon (38). It is therefore possible that the lack of IL-7
in the periphery leads, directly or indirectly, to B cell acti-
vation. However, in a different system, where inducible
deletion of recombination activating gene (Rag)-2 stops B
cell production in the bone marrow soon after birth, the
Figure 6. Antibody production and serum Ig levels. (a) Frequency of IgM and IgG plasma cells in the spleen, and of IgM plasma cells in the bone mar-
row, as determined by ELISA-spot assay in young (6–9 wk) and old (16 wk) mice. Results are displayed as number of antibody-secreting cells per 105
B220IgM-positive cells for wild-type (open symbols) and IL-7/ (closed symbols) mice. (b) IgM, IgG, and IgA serum antibody titers from 6-wk-old
IL-7/ (black bars) and wild-type (white bars) mice. Results show the mean and standard deviation (n  6).
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reduced number of B lymphocytes present in the adult also
show a prominent MZ phenotype, and the compartment
of peritoneal B1 cells is normally represented (38a). This
finding argues that cells with a MZ/B1 phenotype arise in
our mice because they were produced early in life, and not
as a consequence of development in the absence of IL-7.
Available evidence suggests that strong selection operates
to maintain a diverse pool of activated and Ig secreting
cells. Analysis of immunodeficient or irradiated hosts re-
constituted with small numbers of peripheral B cells shows
that even when the total number of B220IgM cells is be-
low normal, the number of activated and Ig secreting B
cells, as well as the titer of serum Ig, can reach normal val-
ues. Furthermore, a small resting B cell pool is only appar-
ent after the compartment of activated cells is significantly
reconstituted (28). Peritoneal B cells of the B1 phenotype
are also easily and quickly reconstituted in such models,
and give rise at high frequency to IgM and IgA plasma cells
(39). Studies conducted in BCR transgenic mice reveal a
stepwise selection for nontransgene-expressing cells in the
progression from pre-B to mature and activated B to Ig-
secreting cells (40), which is taken as evidence that selec-
tion forces operate to regulate the compartment of acti-
vated and plasma cells. One explanation for the results
reported in this paper is therefore that only the MZ and B1
compartments attain full reconstitution as a consequence of
the persistent lymphopenia that results from the strict IL-7–
dependency of adult bone marrow lymphopoesis.
The finding that the B1 compartment is normally repre-
sented even when B cell production is restricted to fetal
and perinatal life, lends support to the idea that this sub-
population originates from a distinct developmental path-
way (10, 23, 41). Our data would suggest as well that MZ
B cells are, to a significant extent, also derived from precur-
sors that are seeded early in life.
In conclusion, we report an example of an adult mouse
where the B lymphocytes originate from an embryonic and
perinatal “layer” (42), shown in this work to be indepen-
dent of IL-7.
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